BL
BIO icon

Balentine LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Balentine LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-482
Closed -$239K – 615
2022
Q2 		$239K Buy
+482
New +$251K 0.01% 492
2020
Q3 		– Sell
-23
Closed -$10K – 232
2020
Q2 		$10K Buy
23
+4
+21% +$1.76K ﹤0.01% 550
2020
Q1 		$7K Buy
+19
New +$6.99K ﹤0.01% 420
2019
Q3 		– Sell
-6
Closed -$2K – 746
2019
Q2 		$2K Buy
+6
New +$1.8K ﹤0.01% 613
2018
Q1 		– Sell
-12
Closed -$3K – 115
2017
Q4 		$3K Hold
12
– – ﹤0.01% 556
2017
Q3 		$3K Hold
12
– – ﹤0.01% 557
2017
Q2 		$3K Hold
12
– – ﹤0.01% 527
2017
Q1 		$2K Buy
+12
New +$2.31K ﹤0.01% 541

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return